Ali Zarrinpar, M.D., serves as key investigator on grant-awarded research.

Published: April 15th, 2019

Category: Ali Zarrinpar, Awards, fatty liver disease, News & Announcements, Research

Ali Zarrinpar, M.D.Ali Zarrinpar, M.D., is serving as a key investigator on research that has been awarded a 5-star NIH RO1 grant entitled “Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics.” The grant, headed by Theodore C. Friedman, M.D., Ph. D., and other researchers at Charles R. Drew University of Medicine and Science, addresses the health disparity of fatty liver disease, a common condition that can lead to cirrhosis. Hispanics have a much higher prevalence of this disease, and a lack of therapy has had a harmful effect on the population. It is the hope of the researchers that their study will uncover new genes involved in the development of this disease, and lead to therapies that will improve the health of Hispanics in the United States.